Bayer teams up with Huma to apply AI to lung cancer diagnosis
pharmaphorum
SEPTEMBER 29, 2021
A research project between Bayer and digital health company Huma will use artificial intelligence to detect lung cancer in CT scans – and determine which type a patient has, in order to direct treatment. AI is already being applied by a number of groups, with some studies indicating it can even be more effective than trained radiologists in detecting subtle patterns that indicate the presence of tumours.
Let's personalize your content